|
TIAL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.46149758961656E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.36650000204241E-08 |
| Normal-vs-Stage2 |
5.7908999817613E-10 |
| Normal-vs-Stage3 |
1.0821010754114E-11 |
| Normal-vs-Stage4 |
1.06239999997371E-06 |
| Stage1-vs-Stage2 |
2.077700E-02 |
| Stage1-vs-Stage3 |
1.330060E-02 |
| Stage1-vs-Stage4 |
4.093800E-01 |
| Stage2-vs-Stage3 |
6.514400E-01 |
| Stage2-vs-Stage4 |
2.660600E-01 |
| Stage3-vs-Stage4 |
3.655200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.87410103996899E-11 |
| Normal-vs-AfricanAmerican |
7.777400E-04 |
| Normal-vs-Asian |
3.56129999999899E-05 |
| Caucasian-vs-AfricanAmerican |
3.432000E-01 |
| Caucasian-vs-Asian |
2.383600E-01 |
| AfricanAmerican-vs-Asian |
9.477000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.6900000267035E-09 |
| Normal-vs-Female |
4.04120070740532E-11 |
| Male-vs-Female |
5.521800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.23060000365183E-08 |
| Normal-vs-Age(41-60Yrs) |
7.9211082137931E-12 |
| Normal-vs-Age(61-80Yrs) |
1.24099996945404E-09 |
| Normal-vs-Age(81-100Yrs) |
8.05440000000157E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.391800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.028820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.898970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.838600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.603000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.877600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.410350E-04 |
| Classical-VS-Follicular |
2.095700E-02 |
| Classical-VS-Other |
8.080000E-01 |
| Classical-VS-Normal |
2.18360000081574E-08 |
| Tall-VS-Follicular |
1.671570E-01 |
| Tall-VS-Other |
1.858220E-01 |
| Tall-VS-Normal |
6.23689988543674E-11 |
| Follicular-VS-Other |
3.609000E-01 |
| Follicular-VS-Normal |
1.47589995780351E-09 |
| Other-VS-Normal |
5.222000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.69444491560489E-12 |
| Normal-vs-N1 |
1.215250E-04 |
| N0-vs-N1 |
2.167200E-01 |
|
|
